Germany
Sequent Scientific Ltd (BOM:512529) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Record EBITDA
Revenue: INR3,902 million, 17.1% YoY growth, 8% sequential growth.EBITDA pre-ESOP: INR483 million, highest in the last three years, 12.4% margin.Formulation Bu